CTOs on the Move

New Reach Education

www.newreacheducation.com

 
CHANGING THE INVESTMENT AND FINANCIAL EDUCATION SPACE
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Veea

Veea allows you to get real-time local knowledge about places.

RISE CREATIVE STUDIO

Rise Creative Studio is a creative consultancy that specializes in brand design strategy for the outdoor industry. They deliver innovative, meaningful proposals that manifest into unprecedented category winners.

Venn

Leading secure workspace that isolates and protects work from any personal use on one computer. Give your remote teams the best BYOD security. Meet Venn!

Great Question

The #1 platform to help you automate your UX research operations - from recruitment, to scheduling and incentives. BYO customers, or leverage our panel

Kapost

Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.